BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7340890)

  • 1. A comparative study of atenolol and metoprolol in the treatment of hypertension.
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol and metoprolol once daily in hypertension.
    Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.
    Morley CA; Cavalcanti C; Perrins EJ; Sutton R
    Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period.
    Crowe PF; Ferguson RJ
    Curr Med Res Opin; 1985; 9(7):431-5. PubMed ID: 4028805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of time and physical activity on blood pressure and heart rate during treatment with beta-blocking agents once daily.
    Danielson M; Kjellberg J; Kuylenstierna J; Lundkvist L; Svensson O
    Acta Med Scand; 1983; 214(5):381-5. PubMed ID: 6362342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG; Hampton JR
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.
    Silas JH; Freestone S; Lennard MS; Ramsay LE
    Br J Clin Pharmacol; 1985 Oct; 20(4):387-91. PubMed ID: 4074607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma.
    Carlson C; Järvinen KA
    Allergy; 1978 Jun; 33(3):147-51. PubMed ID: 707790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
    Houtzagers JJ; Chadha DR
    J Int Med Res; 1982; 10(1):1-5. PubMed ID: 7060821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative activity of atenolol and metoprolol.
    Harry JD
    Br Med J; 1978 Aug; 2(6137):640-1. PubMed ID: 698639
    [No Abstract]   [Full Text] [Related]  

  • 19. Metoprolol or atenolol for mild-to-moderate hypertension.
    Lyngstam O; Rydén L
    Lancet; 1979 Sep; 2(8143):634. PubMed ID: 90293
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.